secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2022-08-04T23:59:59+00:00
Accession:  0001636422-22-000038
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst Q2 revenue up 18% to $70.6M; lowers full-year guidance
----------------------------------------------------------------------

- Total revenue $70.6M, up 18% YoY; Technology revenue $45.4M (+28%), Professional services $25.2M (+5%).
- GAAP net loss $33.4M vs $35.8M loss a year ago; Adjusted EBITDA $2.0M, up 20%.
- Adjusted Technology Gross Margin 70%, Adjusted Professional Services Gross Margin 27%.
- Revising down full-year 2022 revenue and Adjusted EBITDA outlook citing challenging end-market environment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642222000038/0001636422-22-000038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642222000038/hcat-20220804.htm
  HTML page:      https://secwatch.observer/filing/0001636422-22-000038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer